vs
Encompass Health Corp（EHC）与Rocket Companies, Inc.（RKT）财务数据对比。点击上方公司名可切换其他公司
Rocket Companies, Inc.的季度营收约是Encompass Health Corp的1.7倍（$2.7B vs $1.5B），Encompass Health Corp净利率更高（9.5% vs 2.5%，领先6.9%），Rocket Companies, Inc.同比增速更快（52.2% vs 9.9%），Encompass Health Corp自由现金流更多（$116.7M vs $-1.3B），过去两年Rocket Companies, Inc.的营收复合增速更高（39.5% vs 8.3%）
Encompass Health Corp前身为Amcare及HealthSouth，总部位于美国阿拉巴马州伯明翰，是美国规模最大的住院康复服务提供商，在39个州及波多黎各拥有173家住院康复医院，为中风、神经系统疾病、心肺病症、脑损伤等患者提供专业康复诊疗服务。
Rocket Companies, Inc.是美国金融科技及住房服务企业，由丹·吉尔伯特创立，总部位于密歇根州底特律市中心。公司依托旗舰子公司Rocket Mortgage跻身美国最大抵押贷款提供商行列，旗下还拥有Redfin、Forsalebyowner.com、Rocket Money等子品牌。
EHC vs RKT — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.5B | $2.7B |
| 净利润 | $146.1M | $68.0M |
| 毛利率 | — | — |
| 营业利润率 | 16.7% | 6.3% |
| 净利率 | 9.5% | 2.5% |
| 营收同比 | 9.9% | 52.2% |
| 净利润同比 | 20.8% | 100.8% |
| 每股收益（稀释后） | $1.43 | $0.10 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $1.5B | $2.7B | ||
| Q3 25 | $1.5B | $1.6B | ||
| Q2 25 | $1.5B | $1.4B | ||
| Q1 25 | $1.5B | $1.0B | ||
| Q4 24 | $1.4B | $1.8B | ||
| Q3 24 | $1.4B | $646.9M | ||
| Q2 24 | $1.3B | $1.3B | ||
| Q1 24 | $1.3B | $1.4B |
| Q4 25 | $146.1M | $68.0M | ||
| Q3 25 | $126.5M | $-123.9M | ||
| Q2 25 | $142.1M | $-1.8M | ||
| Q1 25 | $151.5M | $-10.4M | ||
| Q4 24 | $120.9M | $33.9M | ||
| Q3 24 | $108.2M | $-22.0M | ||
| Q2 24 | $114.1M | $1.3M | ||
| Q1 24 | $112.5M | $16.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 58.9% | ||
| Q3 24 | — | -8.4% | ||
| Q2 24 | — | 47.4% | ||
| Q1 24 | — | 51.2% |
| Q4 25 | 16.7% | 6.3% | ||
| Q3 25 | 14.9% | -11.5% | ||
| Q2 25 | 16.2% | 1.8% | ||
| Q1 25 | 16.4% | -21.5% | ||
| Q4 24 | 14.3% | 38.1% | ||
| Q3 24 | 13.6% | -76.9% | ||
| Q2 24 | 14.3% | 14.8% | ||
| Q1 24 | 13.6% | 21.6% |
| Q4 25 | 9.5% | 2.5% | ||
| Q3 25 | 8.6% | -7.7% | ||
| Q2 25 | 9.7% | -0.1% | ||
| Q1 25 | 10.4% | -1.0% | ||
| Q4 24 | 8.6% | 1.9% | ||
| Q3 24 | 8.0% | -3.4% | ||
| Q2 24 | 8.8% | 0.1% | ||
| Q1 24 | 8.5% | 1.2% |
| Q4 25 | $1.43 | $0.10 | ||
| Q3 25 | $1.24 | $-0.06 | ||
| Q2 25 | $1.39 | $-0.01 | ||
| Q1 25 | $1.48 | $-0.08 | ||
| Q4 24 | $1.18 | $0.28 | ||
| Q3 24 | $1.06 | $-0.19 | ||
| Q2 24 | $1.12 | $0.01 | ||
| Q1 24 | $1.10 | $0.11 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $72.2M | $2.7B |
| 总债务越低越好 | $2.4B | — |
| 股东权益账面价值 | $2.4B | $22.9B |
| 总资产 | $7.1B | $60.7B |
| 负债/权益比越低杠杆越低 | 1.00× | — |
8季度趋势，按日历期对齐
| Q4 25 | $72.2M | $2.7B | ||
| Q3 25 | $48.7M | $5.8B | ||
| Q2 25 | $99.1M | $5.1B | ||
| Q1 25 | $95.8M | $1.4B | ||
| Q4 24 | $85.4M | $1.3B | ||
| Q3 24 | $147.8M | $1.2B | ||
| Q2 24 | $154.4M | $1.3B | ||
| Q1 24 | $134.4M | $861.4M |
| Q4 25 | $2.4B | — | ||
| Q3 25 | $2.4B | — | ||
| Q2 25 | $2.3B | — | ||
| Q1 25 | $2.3B | — | ||
| Q4 24 | $2.4B | — | ||
| Q3 24 | $2.3B | — | ||
| Q2 24 | $2.7B | — | ||
| Q1 24 | $2.7B | — |
| Q4 25 | $2.4B | $22.9B | ||
| Q3 25 | $2.4B | $8.9B | ||
| Q2 25 | $2.3B | $7.4B | ||
| Q1 25 | $2.2B | $8.6B | ||
| Q4 24 | $2.1B | $9.0B | ||
| Q3 24 | $2.0B | $8.4B | ||
| Q2 24 | $1.8B | $8.8B | ||
| Q1 24 | $1.7B | $8.6B |
| Q4 25 | $7.1B | $60.7B | ||
| Q3 25 | $6.9B | $33.6B | ||
| Q2 25 | $6.8B | $30.4B | ||
| Q1 25 | $6.6B | $25.3B | ||
| Q4 24 | $6.5B | $24.5B | ||
| Q3 24 | $6.5B | $25.1B | ||
| Q2 24 | $6.4B | $23.6B | ||
| Q1 24 | $6.2B | $22.2B |
| Q4 25 | 1.00× | — | ||
| Q3 25 | 1.01× | — | ||
| Q2 25 | 1.02× | — | ||
| Q1 25 | 1.08× | — | ||
| Q4 24 | 1.14× | — | ||
| Q3 24 | 1.20× | — | ||
| Q2 24 | 1.46× | — | ||
| Q1 24 | 1.54× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $346.0M | $-1.2B |
| 自由现金流经营现金流 - 资本支出 | $116.7M | $-1.3B |
| 自由现金流率自由现金流/营收 | 7.6% | -47.2% |
| 资本支出强度资本支出/营收 | 14.8% | 1.5% |
| 现金转化率经营现金流/净利润 | 2.37× | -18.08× |
| 过去12个月自由现金流最近4个季度 | $439.2M | $-4.0B |
8季度趋势，按日历期对齐
| Q4 25 | $346.0M | $-1.2B | ||
| Q3 25 | $270.8M | $-50.3M | ||
| Q2 25 | $270.2M | $-1.9B | ||
| Q1 25 | $288.6M | $-797.0M | ||
| Q4 24 | $278.8M | $1.8B | ||
| Q3 24 | $267.8M | $-1.3B | ||
| Q2 24 | $217.4M | $-122.3M | ||
| Q1 24 | $238.8M | $-3.0B |
| Q4 25 | $116.7M | $-1.3B | ||
| Q3 25 | $83.7M | $-71.8M | ||
| Q2 25 | $113.3M | $-1.9B | ||
| Q1 25 | $125.5M | $-811.0M | ||
| Q4 24 | $80.1M | $1.8B | ||
| Q3 24 | $120.3M | $-1.4B | ||
| Q2 24 | $60.5M | $-138.3M | ||
| Q1 24 | $99.4M | $-3.0B |
| Q4 25 | 7.6% | -47.2% | ||
| Q3 25 | 5.7% | -4.5% | ||
| Q2 25 | 7.8% | -137.2% | ||
| Q1 25 | 8.6% | -78.2% | ||
| Q4 24 | 5.7% | 103.1% | ||
| Q3 24 | 8.9% | -209.6% | ||
| Q2 24 | 4.6% | -10.6% | ||
| Q1 24 | 7.6% | -218.7% |
| Q4 25 | 14.8% | 1.5% | ||
| Q3 25 | 12.7% | 1.3% | ||
| Q2 25 | 10.8% | 1.1% | ||
| Q1 25 | 11.2% | 1.4% | ||
| Q4 24 | 14.1% | 1.1% | ||
| Q3 24 | 10.9% | 2.9% | ||
| Q2 24 | 12.1% | 1.2% | ||
| Q1 24 | 10.6% | 1.0% |
| Q4 25 | 2.37× | -18.08× | ||
| Q3 25 | 2.14× | — | ||
| Q2 25 | 1.90× | — | ||
| Q1 25 | 1.90× | — | ||
| Q4 24 | 2.31× | 54.42× | ||
| Q3 24 | 2.48× | — | ||
| Q2 24 | 1.91× | -94.46× | ||
| Q1 24 | 2.12× | -185.80× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
EHC
| Medicare | $1.0B | 66% |
| Medicare Advantage | $243.1M | 16% |
| Managed Care | $160.7M | 10% |
| Medicaid | $47.0M | 3% |
| Other Income Source | $44.8M | 3% |
| Other Thirdparty Payors | $11.2M | 1% |
| Workers Compensation | $7.6M | 0% |
| Patients | $4.6M | 0% |
RKT
| Other | $1.4B | 51% |
| Direct To Customer Segment | $945.8M | 35% |
| Partner Network Segment | $216.7M | 8% |
| Subscription Revenue | $91.3M | 3% |
| Closing Fees | $47.1M | 2% |
| Appraisal Revenue | $10.7M | 0% |
